An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance
Crossref DOI link: https://doi.org/10.1186/s12962-016-0058-z
Published Online: 2016-07-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Raykar, Neha
Nigam, Aditi
Chisholm, Dan
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP51229)
Text and Data Mining valid from 2016-07-08
Version of Record valid from 2016-07-08
Article History
Received: 24 June 2015
Accepted: 16 June 2016
First Online: 8 July 2016